metformin with retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy

Structure of GLP-1 (7–36) amide

20.88

★★★★☆4.9 (60)

Buyer beware. New data points to a higher likelihood of adverse events from using compounded GLP-1 meds versus the fda approved branded versions. No I dong get paid by these companies. In fact the

25.32

★★★★★4.4 (15)

Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding

23.95

★★★★★4.9 (217)

Synthesis of human GLP-1 (7–36) by chemoselective α-ketoacid–hydroxylamine peptide ligation of unprotected fragments

22.12

★★★★★4.3 (155)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

21.79

★★★★★4.6 (138)

New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our

23.48

★★★★★4.1 (144)

GLP-1 (7-37, 7-36, amide, free NT) monoclonal antibody (10) (biotin conjugate)

24.79

★★★★★4.8 (217)